tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARWR Stock Latest News

Arrowhead Pharmaceuticals Advances Alzheimer’s Treatment with New Clinical Study
Company AnnouncementsArrowhead Pharmaceuticals Advances Alzheimer’s Treatment with New Clinical Study
2d ago
ARWR
Arrowhead Pharmaceuticals Advances Cholesterol Treatment with Phase 3 Study
PremiumCompany Announcements
Arrowhead Pharmaceuticals Advances Cholesterol Treatment with Phase 3 Study
2d ago
ARWR
Arrowhead Pharmaceuticals Advances in FSHD1 Treatment with ARO-DUX4 Study
PremiumCompany Announcements
Arrowhead Pharmaceuticals Advances in FSHD1 Treatment with ARO-DUX4 Study
2d ago
ARWR
Arrowhead Pharmaceuticals Advances Plozasiran Study for Hypertriglyceridemia
PremiumCompany Announcements
Arrowhead Pharmaceuticals Advances Plozasiran Study for Hypertriglyceridemia
2d ago
ARWR
Arrowhead Pharmaceuticals Advances in SCA2 Treatment with ARO-ATXN2 Study
PremiumCompany Announcements
Arrowhead Pharmaceuticals Advances in SCA2 Treatment with ARO-ATXN2 Study
2d ago
ARWR
Arrowhead Pharmaceuticals’ ARO-INHBE Study: A Potential Game-Changer in Obesity Treatment
PremiumCompany AnnouncementsArrowhead Pharmaceuticals’ ARO-INHBE Study: A Potential Game-Changer in Obesity Treatment
2d ago
ARWR
Arrowhead Pharmaceuticals’ ARO-ALK7 Study: A Potential Game-Changer in Obesity Treatment
Premium
Company Announcements
Arrowhead Pharmaceuticals’ ARO-ALK7 Study: A Potential Game-Changer in Obesity Treatment
2d ago
ARWR
Arrowhead Pharmaceuticals Advances Phase 3 Study on Plozasiran for Severe Hypertriglyceridemia
Premium
Company Announcements
Arrowhead Pharmaceuticals Advances Phase 3 Study on Plozasiran for Severe Hypertriglyceridemia
2d ago
ARWR
Arrowhead Pharmaceuticals Advances ARO-DM1 Study for Myotonic Dystrophy
PremiumCompany Announcements
Arrowhead Pharmaceuticals Advances ARO-DM1 Study for Myotonic Dystrophy
2d ago
ARWR
Arrowhead price target raised to $61 from $38 at B. Riley
PremiumThe Fly
Arrowhead price target raised to $61 from $38 at B. Riley
7d ago
ARWR
Arrowhead files request for regulatory clearance to initiate ARO-DIMER-PA trial
PremiumThe Fly
Arrowhead files request for regulatory clearance to initiate ARO-DIMER-PA trial
22d ago
ARWR
Novartis Stock (NVS) Pops as U.S. Approves Pill to Treat Stubborn Skin Flare-Ups
PremiumMarket News
Novartis Stock (NVS) Pops as U.S. Approves Pill to Treat Stubborn Skin Flare-Ups
28d ago
NVS
PFE
Monte Rosa’s Stock (GLUE) Skyrockets on $5.7B Deal with Novartis
PremiumMarket NewsMonte Rosa’s Stock (GLUE) Skyrockets on $5.7B Deal with Novartis
1M ago
NVS
ARWR
Arrowhead Pharmaceuticals: Strategic Advancements and Promising Pipeline Drive Buy Rating
Premium
Ratings
Arrowhead Pharmaceuticals: Strategic Advancements and Promising Pipeline Drive Buy Rating
1M ago
ARWR
Arrowhead Pharmaceuticals Faces Patent Lawsuit from Ionis
Premium
Company Announcements
Arrowhead Pharmaceuticals Faces Patent Lawsuit from Ionis
2M ago
8K
ARWR
Arrowhead Pharmaceuticals Sues Ionis Over Patent Dispute
PremiumCompany Announcements
Arrowhead Pharmaceuticals Sues Ionis Over Patent Dispute
2M ago
8K
ARWR
Arrowhead files complaint for declaratory judgment against Ionis
PremiumThe Fly
Arrowhead files complaint for declaratory judgment against Ionis
2M ago
ARWR
IONS
Arrowhead requests regulatory clearance to initiate ARO-MAPT clinical trial
PremiumThe Fly
Arrowhead requests regulatory clearance to initiate ARO-MAPT clinical trial
2M ago
ARWR
Sarepta price target raised to $15 from $12 at Leerink
PremiumThe Fly
Sarepta price target raised to $15 from $12 at Leerink
2M ago
ARWR
SRPT
Cautious Optimism: Hold Rating for Arrowhead Pharmaceuticals Amid Novartis Collaboration and Balance Sheet Concerns
PremiumRatingsCautious Optimism: Hold Rating for Arrowhead Pharmaceuticals Amid Novartis Collaboration and Balance Sheet Concerns
2M ago
ARWR
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
2M ago
M
CRM
Arrowhead (ARWR) Stock Soars over $200M Deal with Swiss Pharma Giant Novartis
Premium
Market News
Arrowhead (ARWR) Stock Soars over $200M Deal with Swiss Pharma Giant Novartis
2M ago
NVS
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >